🏥 Health 10h ago · Elaine Chen

STAT+: Once described as obesity medicines for ‘patients,’ GLP-1s are increasingly lifestyle drugs for ‘customers’

STAT News
Reporting from the frontiers of health and medicine
View Channel →
STAT+: Once described as obesity medicines for ‘patients,’ GLP-1s are increasingly lifestyle drugs for ‘customers’
Source ↗ 👁 0 💬 0
Blockbuster GLP-1 drugs have transformed the lives of millions of people. Lately, they’re undergoing a makeover of their own.



Once promoted as tools to address obesity as a medical issue, GLP-1 drugs are increasingly being seen — and marketed — as a way to look and feel better generally. And, as the pioneer in the field, Novo Nordisk, in particular, has leaned into the shift.



In advertisements around the world, the company has trotted out slogans like &#x201C

Comments (0)

Sign in to join the discussion

More Like This

The Decomposition of Intelligence
Psychology Today: The Latest · 3h ago
California firm licenses ‘potent’ anti-measles antibodies from Vanderbilt Health for development, clinical testing
Vanderbilt Health News · 3h ago
Science vs. Philosophy
Psychology Today: The Latest · 3h ago
One Shot or Two? What to Know About HPV Vaccination Recommendations
MedPageToday.com - medical news for physicians · 4h ago
STAT+: It really is bleak out there, and list prices matter
STAT · 4h ago
No Sex Please, We’re Gen Z*
Psychology Today: The Latest · 4h ago